Total Funding
33
68
Total FundingSeries A raised
Growth Score 33 in past quarter
-1 pts
Heat Score 68 in past quarter
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
51696
The company uses its plant-based expression technology to produce a wide range of recombinant proteins for multiple applications.
- Belinda Shaw: CEO & Founder
About the Company
Cape Bio Pharms is a biopharming company that uses its plant-based expression technology to produce a wide range of recombinant proteins for use in biomedical research, in rapid diagnostic test kits and potential vaccine and therapeutic applications. Plant expression technology offers superior economics and a production platform that is agile,
flexible and capable of expressing complex molecular structures. It's also an ethical alternative as no animals are used in the making of its proteins.